Early-Phase Oral Antiviral Use and Post–COVID-19 Condition in Outpatients - Top-Institutions - MDSpire

Early-Phase Oral Antiviral Use and Post–COVID-19 Condition in Outpatients

  • By

  • Makoto Hibino

  • Ayumi Shintani

  • Hiroyuki Murayama

  • Nobuyuki Morikawa

  • Kazunari Maeda

  • Sho Nishiguchi

  • Eiji Monma

  • Hiromasa Harada

  • Tsunekazu Takagi

  • Satoshi Kuroyanagi

  • Kiyoshi Endo

  • Yasushi Terada

  • Masahiro Kinoshita

  • Takahiro Yoden

  • Shogo Miyazawa

  • Shinichi Higashiue

  • May 15, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Tokushukai Medical Group
    Tokushukai Medical Group

    Tokyo, Tokyo

    Key Differentiators

    • Infectious Disease

  • #2

    University Hospital Medical Information Network Clinical Trials Registry
    University Hospital Medical Information Network Clinical Trials Registry

    Tokyo, Tokyo

    Key Differentiators

    • Clinical Trials

  • #3

    University Hospital Bonn
    University Hospital Bonn

    Bonn, North Rhine-Westphalia

    Key Differentiators

    • Infectious Disease

Original Source(s)

Early-Phase Oral Antiviral Use and Post–COVID-19 Condition in Outpatients

  • by Makoto Hibino, Ayumi Shintani, Hiroyuki Murayama, Nobuyuki Morikawa, Kazunari Maeda, Sho Nishiguchi, Eiji Monma, Hiromasa Harada, Tsunekazu Takagi, Satoshi Kuroyanagi, Kiyoshi Endo, Yasushi Terada, Masahiro Kinoshita, Takahiro Yoden, Shogo Miyazawa, Shinichi Higashiue

  • May 15, 2026

Related Content

The latest developments on Ebola, hepatitis B, long Covid

Clinical characteristics and antibody responses to Omicron variants among pregnant women in China during the December 2022–April 2023 COVID-19 pandemic wave

Post-acute metabolic changes and risk of new-onset diabetes following COVID-19: a systematic review and meta-analysis